Top compounds associated with response to EIF2D


Feature Type Standardized
Nominal ANOVA
mRNA MI-2 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA CIL41 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Nilotinib FIMM pan-cancer AAC -0.061 0.7
mRNA tivozanib GDSC1000 pan-cancer AAC -0.012 0.7
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA paclitaxel gCSI pan-cancer AAC 0.019 0.7
mRNA Tamoxifen GDSC1000 pan-cancer AAC 0.012 0.7
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.012 0.7
Download CSV